173 related articles for article (PubMed ID: 28978124)
1. SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma.
Kim YH; Jeong DC; Pak K; Han ME; Kim JY; Liangwen L; Kim HJ; Kim TW; Kim TH; Hyun DW; Oh SO
Oncotarget; 2017 Sep; 8(40):68381-68392. PubMed ID: 28978124
[TBL] [Abstract][Full Text] [Related]
2. Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration.
Peng Q; Hao LY; Guo YL; Zhang ZQ; Ji JM; Xue Y; Liu YW; Lu JL; Li CG; Shi XL
World J Clin Cases; 2022 May; 10(13):3989-4019. PubMed ID: 35665115
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targets.
Liu Y; Li X; Yang J; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Heliyon; 2024 Apr; 10(8):e29655. PubMed ID: 38655365
[TBL] [Abstract][Full Text] [Related]
4. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
5. Clinical implication of glucose transport and metabolism evaluated by 18F-FDG PET in hepatocellular carcinoma.
Paudyal B; Paudyal P; Oriuchi N; Tsushima Y; Nakajima T; Endo K
Int J Oncol; 2008 Nov; 33(5):1047-54. PubMed ID: 18949368
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte nuclear factors 1α/4α and forkhead box A2 regulate the solute carrier 2A2 (Slc2a2) gene expression in the liver and kidney of diabetic rats.
David-Silva A; Freitas HS; Okamoto MM; Sabino-Silva R; Schaan BD; Machado UF
Life Sci; 2013 Nov; 93(22):805-13. PubMed ID: 24157454
[TBL] [Abstract][Full Text] [Related]
7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
8. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
10. Metformin increases the uptake of glucose into the gut from the circulation in high-fat diet-fed male mice, which is enhanced by a reduction in whole-body Slc2a2 expression.
Morrice N; Vainio S; Mikkola K; van Aalten L; Gallagher JR; Ashford MLJ; McNeilly AD; McCrimmon RJ; Grosfeld A; Serradas P; Koffert J; Pearson ER; Nuutila P; Sutherland C
Mol Metab; 2023 Nov; 77():101807. PubMed ID: 37717665
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of SLC2A3 gene and prognosis in colorectal carcinoma: analysis of TCGA data.
Kim E; Jung S; Park WS; Lee JH; Shin R; Heo SC; Choe EK; Lee JH; Kim K; Chai YJ
BMC Cancer; 2019 Apr; 19(1):302. PubMed ID: 30943948
[TBL] [Abstract][Full Text] [Related]
12. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma.
Li G; Zhong Y; Shen Q; Zhou Y; Deng X; Li C; Chen J; Zhou Y; He M
Int J Oncol; 2017 Feb; 50(2):405-413. PubMed ID: 28101574
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of glucose transporter 3 expression in hepatocellular carcinoma.
Gao H; Hao Y; Zhou X; Li H; Liu F; Zhu H; Song X; Niu Z; Ni Q; Chen MS; Lu J
Oncol Lett; 2020 Jan; 19(1):691-699. PubMed ID: 31885715
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
16. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection.
Zhang ZF; Feng XS; Chen H; Duan ZJ; Wang LX; Yang D; Liu PX; Zhang QP; Jin YL; Sun ZG; Liu H
BMC Gastroenterol; 2016 Jun; 16(1):57. PubMed ID: 27255554
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
Han XJ; Su HY; Shao HB; Xu K
World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.
Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF
World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768
[TBL] [Abstract][Full Text] [Related]
20.
Na SJ; Oh JK; Hyun SH; Lee JW; Hong IK; Song BI; Kim TS; Eo JS; Lee SW; Yoo IR; Chung YA; Yun M
J Nucl Med; 2017 May; 58(5):730-736. PubMed ID: 27789714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]